Author pages are created from data sourced from our academic publisher partnerships and public sources.
Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
In contrast to patients with disseminated intravascular coagulation (DIC) due to other causes, patients with acute promyelocytic leukemia (APL) receiving standard cytotoxic chemotherapy can be… Expand
Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17).
We recently established an acute promyelocytic leukemia (APL) cell line (HT93) that has the capacity to differentiate into neutrophils and eosinophils in response to all-trans retinoic acid (ATRA)… Expand
Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils.
BACKGROUND No technique has been reported to analyze directly the antigen expression on basophil leukocytes when using a flow cytometer; therefore, the exact phenotype of human basophils and the… Expand
Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor
- T. Furukawa, M. Narita, +9 authors Yuji Aizawa
- Medicine, Biology
- British journal of haematology
- 1 October 1997
Primary familial and congenital polycythaemia (PFCP) is a rare disease characterized by congenital erythrocytosis inherited in an autosomal dominant fashion. Recently, mutations in the erythropoietin… Expand
Usefulness of vital staining with iodine solution for diagnosis of oral dysplastic lesions
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
- Shigeru Fujimori, H. Kurita, +5 authors K. Kurashina
- Gan to kagaku ryoho. Cancer & chemotherapy
- 1 May 2003
The purpose of this study was to evaluate the effect of preoperative combination chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas. Eleven patients were enrolled in this study… Expand